Sign in
CompletedNo phase

Sarcopenia and Peripheral Artery Disease With Chronic Limb Threatening Ischemia

Key facts

Who runs it
Fudan University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
97 people enrolled
Started
1 Jan 2023
Ended
31 Dec 2024
Type of study
Observational
Treatments tested
  • Not applicable- observational study
Record updated
26 June 2025

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Patients of Peripheral Artery Disease, including intermittent claudication and Chronic Limb Threatening Ischemia
  • Patients with Rutherford grade 2-6 between Jan.1 2023 and Dec.31 2024
  • Patients at age 18-80
  • Patients underwent an in-hospital routine enhanced whole abdomen to lower extremities CT scan
  • Patients able to complete the clinical follow-up for 3 months

Who cannot take part

  • Poor CT quality or incomplete images
  • Incomplete clinical data
  • In-hospital mortality during Jan.1 2023 and Dec.31 2024

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To evaluate the correlation of Sarcopenia Parameters and Peripheral Artery Disease with chronic limb threatening ischaemia.

The group in the trial

  • patiets with peripheral artery disease

    Treatment: Not applicable- observational study

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Correlation of Sarcopenia and Peripheral Artery Disease With Chronic Limb Threatening Ischemia
Record updated
26 June 2025